[Prognostic assessment and treatment of early breast cancer].
Noémi Amsellem, Barbara Pistilli
Abstract
Noémi Amsellem, Barbara Pistilli
Abstract
Prognostic assessment and treatment of early breast cancer. Breast cancer is the most common cancer occurring in France and worldwide. In 2017 it has been estimated that 59.000 women in France have been diagnosed with breast cancer. Breast cancer prognosis depends on multiple factors: tumor stage (TNM), histology, molecular sub-type and grade. The treatment of early breast cancer usually involves different strategies, such as surgery, chemotherapy, endocrine therapy, targeted therapies and radiotherapy, on the basis of the different sub-types.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Prognostic assessment and treatment of early breast cancer. Breast cancer is the most common cancer occurring in France and worldwide. In 2017 it has been estimated that 59.000 women in France have been diagnosed with breast cancer. Breast cancer prognosis depends on multiple factors: tumor stage (TNM), histology, molecular sub-type and grade. The treatment of early breast cancer usually involves different strategies, such as surgery, chemotherapy, endocrine therapy, targeted therapies and radiotherapy, on the basis of the different sub-types.
Key concepts: Breast cancer, Medicine, Radiation therapy, Oncology, Stage (stratigraphy), Chemotherapy, Cancer, Internal medicine